RE: Why would anyone?14 Apr 2019 15:11
gaj1. Agree with you that normal discussion is not easy, due to a very few folks who regard holders chatting to each other as something to be discouraged.
The increase in the numbers on Fruitflow + despatches can only mean that more packs are being sold. I don't agree with Bella/Farmgal on this, but appreciate she is just having a stab at it. Are H&B sales included on this sequence? We just don't know. All we can do is await the updates, hoping to see indications that revenues can grow in the way we hope for. More revenues should equate to more funds to promote, leading to higher sales, the classic growth path for smaller companies who lack the spending power of the majors.
Of course, this is just the in house Provexis retail product. There are many others, supplied by DSM, with marketing support being paid to help them launch. The effect of those contributions would hold back revenues in early stages, hopefully that factor has reduced, increasing revenue prospects from DSM.
Then, By Health, potentially the biggie. A company with the resources to promote products in a massive way, as evidenced by their stellar growth path. They have identified a target home market for Fruitflow, and Chinese companies are not staying within their own boundaries, they are acquiring businesses in other areas of the world.
IMHO revenues from them are some way off, but evidence that they are becoming active with live products would be great for sentiment.
All just my view, each to their own in deciding what to do here.
ATB